Meningococcal polysaccharide vaccine group W-135
Meningococcal polysaccharide vaccine group W-135 Uses, Dosage, Side Effects, Food Interaction and all others data.
Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
| Trade Name | Meningococcal polysaccharide vaccine group W-135 |
| Generic | Meningococcal polysaccharide vaccine group W-135 |
| Meningococcal polysaccharide vaccine group W-135 Other Names | Meningococcal polysaccharide antigen group W-135, neisseria meningitidis group W-135 capsular polysaccharide antigen, Neisseria meningitidis group W-135 polysaccharide antigen, A |
| Type | |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Meningococcal polysaccharide vaccine group W-135
